Product NDC: | 0004-1963 |
Proprietary Name: | Rocephin |
Non Proprietary Name: | ceftriaxone sodium |
Active Ingredient(s): | 500 mg/1 & nbsp; ceftriaxone sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0004-1963 |
Labeler Name: | Genentech, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063239 |
Marketing Category: | ANDA |
Start Marketing Date: | 19930813 |
Package NDC: | 0004-1963-01 |
Package Description: | 10 VIAL, GLASS in 1 BOX (0004-1963-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS |
NDC Code | 0004-1963-01 |
Proprietary Name | Rocephin |
Package Description | 10 VIAL, GLASS in 1 BOX (0004-1963-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS |
Product NDC | 0004-1963 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ceftriaxone sodium |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19930813 |
Marketing Category Name | ANDA |
Labeler Name | Genentech, Inc. |
Substance Name | CEFTRIAXONE SODIUM |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |